Cargando…
Pooled evidence from preclinical and clinical studies for stem cell-based therapy in ARDS and COVID-19
COVID-19 has severely devastated many lives across the globe. It has been speculated that stem cell-based therapy for COVID-19 treatment could be able to subsidize the effects. In preclinical and clinical studies, stem cell-based therapy has successfully eliminated inflammatory cytokines in ALI, ARD...
Autores principales: | Murugan, Dhanashree, Rangasamy, Loganathan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9672621/ https://www.ncbi.nlm.nih.gov/pubmed/36394787 http://dx.doi.org/10.1007/s11010-022-04601-2 |
Ejemplares similares
-
A perspective to weaponize microRNAs against lung cancer
por: Murugan, Dhanashree, et al.
Publicado: (2022) -
A Perspective on Newly Emerging Proteolysis-Targeting Strategies in Antimicrobial Drug Discovery
por: Venkatesan, Janarthanan, et al.
Publicado: (2022) -
Nanoparticle Enhancement of Natural Killer (NK) Cell-Based Immunotherapy
por: Murugan, Dhanashree, et al.
Publicado: (2022) -
Can 3D-Printed Bioactive Glasses Be the Future of Bone Tissue Engineering?
por: Dukle, Amey, et al.
Publicado: (2022) -
Mesenchymal Stem Cell-Derived Exosomes for COVID-19 Therapy, Preclinical and Clinical Evidence
por: Kiaie, Nasim, et al.
Publicado: (2021)